We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Pelikan Technologies Acquires Inventus BioTech

By Labmedica staff writers
Posted on 28 Dec 2004
Print article
A leading developer of handheld diagnostic products, Pelikan Technologies, Inc. (Palo Alto, CA, USA), has acquired Inventus BioTech GmbH & Co. KG (Munster, Germany) and renamed the company Albatros Technologies GmbH & Co. KG. Financial terms were not disclosed.

The acquisition provides Pelikan with the Inventus GlucoSens sensor, an innovative electrochemical device designed to measure blood glucose and also other analytes. This gives Pelikan the necessary technology and intellectual property to finalize development of its next-generation, fully integrated lancing and glucose-monitoring system for the management of diabetes. In addition, the company also gains access to the critical sensor manufacturing facilities and processes of Inventus. Pelikan has retained the entire Inventus employee base that will now contribute to the accelerated development of its glucose-monitoring system.

The new system will combine the Pelikan Sun electronic lancing product with the one-step glucose-measurement technology of Inventus. An integrated 50-test disposable disk eliminates the need to handle messy strips or sharp lancets, enhancing both safety and convenience. Precise control works with 30 depth settings to allow people of all ages and skin types to reliably lance their skin to the shallowest depth possible. As a result, pain is reduced and skin-healing improved.

"These advantages position the technology as a perfect fit for Pelikan and the company's objective of revolutionizing the mangement of diabetes,” said Prof. Anthony Turner, Ph.D., DSc, head of Pelikan's scientific advisory board. Pelikan was spun off from Agilent Technologies in 2001.





Related Links:
Pelikan Technologies
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit
New
Lab Sample Rotator
H5600 Revolver

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.